The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Microsoft ResearchResearch

Improving synthesis prediction of small molecules at scale with RetroChimera

September 21

At a glance We report on the recent publication of our retrosynthesis model RetroChimera in the journal Nature (opens in new tab) .

Read at Microsoft Research ↗

More from Microsoft Research on Accept All

ResearchGigaPath-Flash and GigaTIME-Flash: Toward population-scale discovery with efficient pathology foundation models Microsoft Research

ResearchBroadening access to Skala creates a faster path to predictive DFT Microsoft Research

ResearchMindTopo reveals VLMs’ spatial reasoning abilities Microsoft Research

ResearchIntroducing CARE-X: Towards Clinically Useful Radiology VLMs with Auxiliary Supervision, Reward-Aligned Learning, and Tool-Augmented Measurement Microsoft Research

One letter a week, in your inbox.

Latest